Brief: Enochian Biosciences Awarded U.S. Patent For Its Oncology Platform
17/10/2022 14:34
Oct 17 (Reuters) - Enochian Biosciences Inc ENOB.O :
* ENOCHIAN BIOSCIENCES AWARDED U.S. PATENT FOR ITS PROMISING
ONCOLOGY PLATFORM
Source text for Eikon: ID:nGNX50tmcr
Further company coverage: ENOB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lunai Bioworks
See all newsNASDAQ RESUMED AT 02:16 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
Brief: Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Brief: Lunai Bioworks Signs Agreement With Brainstorm Therapeutics
Brief: Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing